ArticleScience translational medicine2020

Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor models.

Qun Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.